Medicure Historical Income Statement

MPH Stock

CAD 0.99 0.09 10.00%

Historical analysis of Medicure income statement accounts such as Other Operating Expenses of 17.9 M can show how well Medicure performed in making a profits. Evaluating Medicure income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Medicure's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Medicure latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medicure is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Medicure Income Statement Analysis

Medicure Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Medicure shareholders. The income statement also shows Medicure investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Medicure Income Statement Chart

At this time, Medicure's Research Development is fairly stable compared to the past year. EBITDA is likely to climb to about 1.4 M in 2024, whereas Total Revenue is likely to drop slightly above 11.8 M in 2024.

Total Revenue Gross Profit Other Operating Expenses Research Development

Total Revenue

Total revenue comprises all receipts Medicure generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Medicure minus its cost of goods sold. It is profit before Medicure operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Medicure. It is also known as Medicure overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Medicure's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Medicure current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medicure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Total Revenue	21.7M	23.1M	21.7M	11.8M
Depreciation And Amortization	3.1M	2.1M	2.2M	1.2M

Total Revenue Depreciation And Amortization

Medicure income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Net Income	Income Before Tax	Total Other Income Expense Net	Income Tax Expense	Interest Expense	Cost Of Revenue	Selling General Administrative	Net Income From Continuing Ops	Minority Interest	Discontinued Operations	Tax Provision	Net Interest Income	Selling And Marketing Expenses	Reconciled Depreciation	Interest Income
Depreciation And Amortization		0.25	0.01	0.44	-0.32	-0.36	-0.15	-0.18	0.22	-0.36	-0.09	-0.1	0.3	-0.4	0.75	-0.23	-0.24	-0.11	0.57	0.2	0.53	-0.6	-0.57	-0.81
Total Revenue	0.25		0.97	0.92	0.4	0.4	0.72	0.47	0.9	0.37	0.37	0.19	-0.21	-0.26	0.66	0.61	0.54	0.05	0.46	-0.29	0.4	0.15	-0.34	-0.11
Gross Profit	0.01	0.97		0.83	0.51	0.52	0.78	0.54	0.87	0.47	0.41	0.21	-0.3	-0.21	0.47	0.68	0.61	0.08	0.32	-0.36	0.28	0.29	-0.21	0.08
Other Operating Expenses	0.44	0.92	0.83		0.04	0.09	0.75	0.19	0.97	0.11	0.11	-0.02	-0.12	-0.38	0.8	0.51	0.25	-0.07	0.66	-0.23	0.69	0.06	-0.62	-0.31
Operating Income	-0.32	0.4	0.51	0.04		0.87	0.12	0.86	0.07	0.71	0.72	0.56	-0.24	0.15	-0.05	0.38	0.86	0.02	-0.34	-0.22	-0.52	0.1	0.49	0.25
Ebit	-0.36	0.4	0.52	0.09	0.87		0.18	0.98	0.14	0.89	0.59	0.42	-0.64	0.05	-0.05	0.17	0.81	0.03	-0.12	-0.63	-0.32	0.08	0.45	0.23
Research Development	-0.15	0.72	0.78	0.75	0.12	0.18		0.17	0.87	0.22	0.06	-0.02	-0.26	-0.1	0.37	0.7	0.31	-0.11	0.3	-0.3	0.45	0.29	-0.35	0.09
Ebitda	-0.18	0.47	0.54	0.19	0.86	0.98	0.17		0.2	0.86	0.6	0.42	-0.61	-0.04	0.12	0.13	0.8	-0.05	-0.01	-0.63	-0.22	-0.06	0.34	0.06
Total Operating Expenses	0.22	0.9	0.87	0.97	0.07	0.14	0.87	0.2		0.16	0.09	-0.06	-0.2	-0.39	0.65	0.6	0.26	-0.08	0.59	-0.3	0.66	0.2	-0.57	-0.16
Net Income	-0.36	0.37	0.47	0.11	0.71	0.89	0.22	0.86	0.16		0.72	0.63	-0.63	0.15	-0.07	0.21	0.77	0.13	-0.14	-0.64	-0.29	0.14	0.47	0.34
Income Before Tax	-0.09	0.37	0.41	0.11	0.72	0.59	0.06	0.6	0.09	0.72		0.94	0.07	0.09	0.1	0.47	0.75	0.06	-0.3	0.02	-0.37	0.09	0.31	0.21
Total Other Income Expense Net	-0.1	0.19	0.21	-0.02	0.56	0.42	-0.02	0.42	-0.06	0.63	0.94		0.19	0.36	0.03	0.43	0.67	0.12	-0.4	0.16	-0.44	0.08	0.36	0.25
Income Tax Expense	0.3	-0.21	-0.3	-0.12	-0.24	-0.64	-0.26	-0.61	-0.2	-0.63	0.07	0.19		0.1	0.11	0.25	-0.24	-0.07	-0.23	0.98	-0.08	-0.02	-0.25	-0.15
Interest Expense	-0.4	-0.26	-0.21	-0.38	0.15	0.05	-0.1	-0.04	-0.39	0.15	0.09	0.36	0.1		-0.31	0.09	0.29	0.22	-0.59	0.2	-0.61	0.18	0.55	0.44
Cost Of Revenue	0.75	0.66	0.47	0.8	-0.05	-0.05	0.37	0.12	0.65	-0.07	0.1	0.03	0.11	-0.31		0.17	0.15	-0.41	0.62	-0.02	0.64	-0.38	-0.65	-0.69
Selling General Administrative	-0.23	0.61	0.68	0.51	0.38	0.17	0.7	0.13	0.6	0.21	0.47	0.43	0.25	0.09	0.17		0.56	0.09	-0.09	0.22	0.03	0.46	-0.14	0.31
Net Income From Continuing Ops	-0.24	0.54	0.61	0.25	0.86	0.81	0.31	0.8	0.26	0.77	0.75	0.67	-0.24	0.29	0.15	0.56		0.06	-0.24	-0.25	-0.36	0.09	0.38	0.24
Minority Interest	-0.11	0.05	0.08	-0.07	0.02	0.03	-0.11	-0.05	-0.08	0.13	0.06	0.12	-0.07	0.22	-0.41	0.09	0.06		-0.24	-0.03	-0.31	0.38	0.37	0.51
Discontinued Operations	0.57	0.46	0.32	0.66	-0.34	-0.12	0.3	-0.01	0.59	-0.14	-0.3	-0.4	-0.23	-0.59	0.62	-0.09	-0.24	-0.24		-0.34	0.91	-0.29	-0.81	-0.67
Tax Provision	0.2	-0.29	-0.36	-0.23	-0.22	-0.63	-0.3	-0.63	-0.3	-0.64	0.02	0.16	0.98	0.2	-0.02	0.22	-0.25	-0.03	-0.34		-0.2	0.01	-0.14	-0.06
Net Interest Income	0.53	0.4	0.28	0.69	-0.52	-0.32	0.45	-0.22	0.66	-0.29	-0.37	-0.44	-0.08	-0.61	0.64	0.03	-0.36	-0.31	0.91	-0.2		-0.22	-0.93	-0.64
Selling And Marketing Expenses	-0.6	0.15	0.29	0.06	0.1	0.08	0.29	-0.06	0.2	0.14	0.09	0.08	-0.02	0.18	-0.38	0.46	0.09	0.38	-0.29	0.01	-0.22		0.2	0.79
Reconciled Depreciation	-0.57	-0.34	-0.21	-0.62	0.49	0.45	-0.35	0.34	-0.57	0.47	0.31	0.36	-0.25	0.55	-0.65	-0.14	0.38	0.37	-0.81	-0.14	-0.93	0.2		0.69
Interest Income	-0.81	-0.11	0.08	-0.31	0.25	0.23	0.09	0.06	-0.16	0.34	0.21	0.25	-0.15	0.44	-0.69	0.31	0.24	0.51	-0.67	-0.06	-0.64	0.79	0.69

Click cells to compare fundamentals

Medicure Account Relationship Matchups

Medicure income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.9M	2.8M	3.1M	2.1M	2.2M	1.2M
Total Revenue	20.2M	11.6M	21.7M	23.1M	21.7M	11.8M
Gross Profit	12.9M	5.1M	12.7M	16.1M	13.6M	8.9M
Other Operating Expenses	28.4M	19.7M	23.8M	21.9M	22.5M	17.9M
Operating Income	(10.7M)	(7.3M)	(574K)	1.3M	(854K)	(896.7K)
Ebit	(10.7M)	(7.3M)	(574K)	1.3M	(854K)	(896.7K)
Research Development	4.3M	3.3M	1.8M	2.8M	2.4M	4.3M
Ebitda	(8.8M)	(4.5M)	2.6M	3.4M	1.3M	1.4M
Total Operating Expenses	21.1M	13.2M	14.8M	14.9M	14.4M	15.0M
Net Income	(19.8M)	(6.8M)	(727K)	1.4M	(922K)	(968.1K)
Income Before Tax	(19.6M)	(6.8M)	(759K)	1.4M	(897K)	(941.9K)
Total Other Income Expense Net	(12.5M)	491K	1.7M	398K	(43K)	(40.9K)
Income Tax Expense	145K	49K	(32K)	20K	25K	23.8K
Interest Expense	22K	49K	38K	23K	20K	19K
Cost Of Revenue	7.3M	6.5M	9.0M	7.0M	8.1M	8.5M
Selling General Administrative	3.4M	4.6M	2.7M	4.2M	4.1M	5.6M
Net Income From Continuing Ops	(19.8M)	(6.8M)	(727K)	1.4M	(922K)	(875.9K)
Net Income Applicable To Common Shares	3.9M	(19.8M)	(6.8M)	(727K)	(654.3K)	(621.6K)
Tax Provision	145K	247K	(32K)	20K	25K	26.3K
Net Interest Income	1.1M	771K	(347K)	(206K)	65K	68.3K
Selling And Marketing Expenses	13.4M	5.4M	10.3M	7.9M	8.3M	8.3M
Reconciled Depreciation	1.9M	2.8M	3.1M	2.1M	2.2M	2.3M
Interest Income	886K	43K	78K	10K	75K	71.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medicure Historical Income Statement

About Medicure Income Statement Analysis

Medicure Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Medicure income statement Correlations

Medicure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medicure income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Medicure Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 0.98	Ebit
Tax Provision	+ 0.98	Income Tax Expense
Gross Profit	+ 0.97	Total Revenue
Total Operating Expenses	+ 0.97	Other Operating Expenses
Total Other Income Expense Net	+ 0.94	Income Before Tax
Other Operating Expenses	+ 0.92	Total Revenue

Reconciled Depreciation	- 0.93	Net Interest Income
Reconciled Depreciation	- 0.81	Discontinued Operations
Interest Income	- 0.81	Depreciation And Amortization
Interest Income	- 0.69	Cost Of Revenue
Interest Income	- 0.67	Discontinued Operations
Reconciled Depreciation	- 0.65	Cost Of Revenue